Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder	Not yet recruiting	Phase 2	2026-06-23		NCT07662031

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Compass Therapeutics	6
Washington University School of Medicine	475

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Washington University School of Medicine	St Louis	United States	895

Clinical trials